Expand ALGS Menu
ALGS MENU

ALGS Latest Press Releases

-- March 5, 2026 --

Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results Globe Newswire 8:00 AM

-- February 26, 2026 --

Aligos Therapeutics to Announce 4th Quarter 2025 Financial Results on March 5, 2026 Globe Newswire 8:00 AM

-- February 23, 2026 --

Aligos Therapeutics Presents Positive Data at the Conference on Retroviruses and Opportunistic Infections (CROI) Globe Newswire 8:00 AM

-- January 30, 2026 --

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 8:00 AM

-- January 21, 2026 --

Aligos Therapeutics Provides Phase 2 B-SUPREME Study Progress Updates Globe Newswire 8:00 AM

-- January 13, 2026 --

Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of James Hassard as Executive Vice President, Chief Commercial Officer Globe Newswire 8:00 AM

-- December 12, 2025 --

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 8:00 AM

-- December 11, 2025 --

Aligos Therapeutics Presents Positive Data at HEP-DART 2025 Globe Newswire 8:00 AM

-- November 14, 2025 --

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 8:00 AM

-- November 10, 2025 --

Aligos Therapeutics Presents Positive Data at The Liver Meeting 2025 Globe Newswire 8:00 AM

-- November 6, 2025 --

Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results Globe Newswire 8:30 AM

-- November 4, 2025 --

Aligos Therapeutics to Present at Upcoming Investor Conferences Globe Newswire 8:30 AM

-- October 30, 2025 --

Aligos Therapeutics to Announce 3rd Quarter 2025 Financial Results on November 6, 2025 Globe Newswire 8:30 AM

-- October 17, 2025 --

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 8:30 AM

-- October 16, 2025 --

Aligos Therapeutics Receives USAN Council Approval for pevifoscorvir sodium as Nonproprietary Name for ALG-000184 Globe Newswire 8:30 AM
Market Data Delayed 15 Minutes